- Home
- GLPI vs MRNA Comparison
GLPI vs MRNA Comparison
Compare GLPI & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- MRNA
- Stock Information
- Founded
- GLPI 2013
- MRNA 2010
- Country
- GLPI United States
- MRNA United States
- Employees
- GLPI N/A
- MRNA N/A
- Industry
- GLPI Real Estate Investment Trusts
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLPI Real Estate
- MRNA Health Care
- Exchange
- GLPI Nasdaq
- MRNA Nasdaq
- Market Cap
- GLPI 13.0B
- MRNA 13.4B
- IPO Year
- GLPI N/A
- MRNA 2018
- Fundamental
- Price
- GLPI $45.81
- MRNA $26.50
- Analyst Decision
- GLPI Buy
- MRNA Hold
- Analyst Count
- GLPI 16
- MRNA 20
- Target Price
- GLPI $52.58
- MRNA $46.24
- AVG Volume (30 Days)
- GLPI 1.8M
- MRNA 8.3M
- Earning Date
- GLPI 07-24-2025
- MRNA 08-01-2025
- Dividend Yield
- GLPI 6.81%
- MRNA N/A
- EPS Growth
- GLPI N/A
- MRNA N/A
- EPS
- GLPI 2.61
- MRNA N/A
- Revenue
- GLPI $1,565,067,000.00
- MRNA $3,078,000,000.00
- Revenue This Year
- GLPI $5.19
- MRNA N/A
- Revenue Next Year
- GLPI $3.54
- MRNA $10.04
- P/E Ratio
- GLPI $17.58
- MRNA N/A
- Revenue Growth
- GLPI 5.38
- MRNA N/A
- 52 Week Low
- GLPI $44.48
- MRNA $23.15
- 52 Week High
- GLPI $52.60
- MRNA $91.99
- Technical
- Relative Strength Index (RSI)
- GLPI 42.87
- MRNA 35.06
- Support Level
- GLPI $45.30
- MRNA $26.57
- Resistance Level
- GLPI $47.10
- MRNA $28.60
- Average True Range (ATR)
- GLPI 0.84
- MRNA 1.42
- MACD
- GLPI -0.08
- MRNA -0.90
- Stochastic Oscillator
- GLPI 20.82
- MRNA 4.49
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.